Head-to-head verdict, factor overlay, rebased prices, and the metrics behind it — up to 5 tickers.
Buy-rated · ~+26% to fair value
Verdict = 50% TENK Score + 30% fair-value upside + 20% our rating, renormalized over available signals. SEC-grounded; an estimate, not advice.
| NVDA NVIDIA CORP $194.83 -1.39% | AAPL Apple Inc. $308.63 +4.84% | MSFT MICROSOFT CORP $390.49 +1.62% | GOOGL Alphabet Inc. $359.91 -0.36% | |
|---|---|---|---|---|
| Our signals | ||||
| Our rating | Hold | Hold | Buy | |
Best value per metric is highlighted in green (direction-aware: lower is better for P/E, EV/EBITDA, EV/Sales, PEG and Debt/Equity). Prices are rebased to 100 at the window start. Fundamentals & our analytics derive from SEC filings; prices are display-only market data.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| Buy |
| TENK Score | 78 | 70 | 77 | 78best |
| Fair-value upside | -4% | -30% | +26%best | +14% |
| Valuation | ||||
|---|---|---|---|---|
| P/E | 39.8 | 41.4 | 28.6best | 33.3 |
| EV / EBITDA | 35.5 | 31.9best | — | — |
| EV / Sales | 21.9 | 11.1 | 10.3best | 10.8 |
| PEG | 0.61best | 2.12 | 1.84 | 1.04 |
| FCF yield | 2.0% | 2.2% | 2.5%best | 1.7% |
| Growth | ||||
|---|---|---|---|---|
| Revenue growth (YoY) | +65.5%best | +6.4% | +14.9% | +15.1% |
| Net income growth (YoY) | +64.7%best | +19.5% | +15.5% | +32.0% |
| Profitability | ||||
|---|---|---|---|---|
| Net margin | 55.6%best | 26.9% | 36.1% | 32.8% |
| Return on equity | 76.3% | 151.9%best | 29.6% | 31.8% |
| ROIC (est.) | 62.1% | 63.9%best | 26.3% | 22.0% |
| Health | ||||
|---|---|---|---|---|
| Liabilities / Equity | 0.31best | 3.87 | 0.80 | 0.43 |
| Altman Z | 62.0best | 11.8 | 8.1 | 16.9 |
| Piotroski | 4 / 9 | 8 / 9best | 5 / 9 | 5 / 9 |
| Shareholder yield | 0.9% | 2.3%best | 1.5% | 1.3% |
| Size | ||||
|---|---|---|---|---|
| Market cap | $4.73T | $4.56T | $2.90T | $4.35T |
Best-in-class compounder: 15% revenue growth, 45.6% op margins, fortress balance sheet — 27x P/E is fair for the quality on offer.
long · 6/23/2026 · 1 caveat
Quality compounder—15% growth, 32% ROE, fortress balance sheet—at a fair-not-cheap 34x; the AI-capex build is the swing factor.
long · 6/19/2026 · 1 caveat